VXRT — VAXART INC (Healthcare >> Biotechnology)
VXRT FAQ
What is VXRT's P/E ratio?
VAXART INC (VXRT) currently trades at a P/E ratio of 2.49.
What is VXRT's ROE?
VAXART INC reports a Return on Equity (ROE) of 39.42%.
What is VXRT's dividend yield?
VAXART INC offers a dividend yield of 0.00%.
What is VXRT's Deepscope Quality Score?
Deepscope rates VXRT's overall financial quality at 54 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy VXRT?
Deepscope's AI Timing Score for VXRT is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does VXRT belong to?
VAXART INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 0.58
Price
-0.02
(-3.12%)
Day Change
|
|
|---|
VXRT Chất lượng tổng thể của cố phiếu Không tốt lắm ( Chất lượng = 54) và Thời điểm mua ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
[-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
Lịch sử ROE tương đối thấp
ROA quá thấp so với ROE
Tốc độ tăng trưởng ROA dưới mức tiêu chí của chúng tôi.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
Lịch sử Biên lợi nhuận ròng tương đối thấp.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Khá , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Không tốt lắm , ...
| Yếu tố Chất lượng |
|
60% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 94 |
| Magic Formula Rank by ROA |
197
|
| Magic Formula Rank by ROE |
197
|
| Magic Formula Rank by ROIC |
100
GOOD
|
| Price | 0.58 |
| PBV / Sector |
1.59 / 4.71
GOOD
|
| Earning Per Share | 0.14 |
| PE / Sector |
2.49 / 17.58
GREAT
|
| PEG or PE/Growth / Sector |
-0.04 / 0.53
|
| Average 1M Daily Value |
0.13 M
GREAT
|
| Average 1W Daily Value |
0.11 M
GREAT
|
| Yếu tố Kỹ thuật |
|
28% |
| Sức khỏe tài chính |
|
45% |
| Khả năng kiếm lợi nhuận |
|
56% |
| Lợi tức cho nhà đầu tư |
|
4% |
| Chi tiết đăng ký |
| Analyze Date | 2026-06-10 09:43:30 |
| Symbol | VXRT |
| Name | VAXART INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 242.04 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 150.07 / 8,889.42 |
| Tin tức, Dự báo ước tính |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 310 Utah Avenue, South San Francisco, CA, United States, 94080
Phone: 650 550 3500
Website: https://vaxart.com
Employees: 65
Sector: Healthcare >> Biotechnology
Description: Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its vector-adjuvant-antigen standardized technology proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII; COVID-19 Vaccine, which is in Phase 2b clinical trial for the treatment of SARS-CoV-1, SARS-CoV-2, and Middle East respiratory syndrome coronavirus; Seasonal Influenza vaccine, which is in Phase 2 clinical trial, to treat H1N1 Influenza; and human papillomavirus therapeutic vaccine, which is in preclinical stage, that targets HPV-16 and HPV-18 for cervical cancers and precancerous cervical lesions. The company also provides VAAST (Vector-Adjuvant-Antigen Standardized Technology) Platform, a unique modular vaccine platform. It has a license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad-spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
Google